DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nplate (Romiplostim Subcutaneous) - Current Clinical Trials

 
 



Nplate Related Clinical Trials

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin [Completed]

Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma [Completed]

Open Label Extension Study of AMG 531 in Japanese Subjects With ITP [Completed]

Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) [Completed]

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy [Suspended]

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) [Completed]

Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) [Completed]

Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) [Completed]

Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia [Suspended]

Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim [Completed]

An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP [Completed]

Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura [Completed]

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy [Completed]

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy [Completed]

Study of Romiplostim Versus Observation for Chemotherapy Induced Thrombocytopenia [Recruiting]

Interventional Study in Adult Subjects With Immune Thrombocytopenia Purpura Receiving Romiplostim [Completed]

A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid [Completed]

Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents [Completed]

Safety Study of AMG 531 in Japanese Subjects With ITP [Completed]

Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training [Recruiting]

Single Arm, Open-label, Long-term Study of Romiplostim in Thrombocytopenic Pediatric Subjects With ITP. [Recruiting]

Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia [Recruiting]

Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects [Completed]

A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune (Idiopathic) Thrombocytopenia Purpura [Recruiting]

P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura [Completed]

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects [Completed]

Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) [Completed]

A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia [Recruiting]

Prevention of Thrombocytopenia in Glioblastoma Patients [Recruiting]

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma [Completed]

NplateŽ Pregnancy Exposure Registry [Terminated]

Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Terminated]

Indirect Comparison Between Eltrombopag & Romiplostim [Completed]

Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) [Completed]

Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety. [Completed]

Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP) [Completed]

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults [Completed]

Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell [Recruiting]

Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology [Completed]

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP) [Recruiting]

TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients. [Recruiting]

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP [Recruiting]

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015